Maridea Wealth Management LLC Invests $2.04 Million in Astera Labs, Inc. $ALAB

Maridea Wealth Management LLC acquired a new stake in Astera Labs, Inc. (NASDAQ:ALAB) in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 4,231 shares of the company’s stock, valued at approximately $2,044,000.

Other institutional investors have also recently added to or reduced their stakes in the company. Trifecta Capital Advisors LLC acquired a new stake in Astera Labs in the 2nd quarter worth about $79,000. Everett Harris & Co. CA purchased a new stake in Astera Labs in the 2nd quarter valued at about $261,000. Oppenheimer Asset Management Inc. acquired a new position in shares of Astera Labs during the 2nd quarter valued at about $3,957,000. Accel Wealth Management acquired a new position in shares of Astera Labs during the 2nd quarter valued at about $317,000. Finally, Handelsbanken Fonder AB lifted its holdings in shares of Astera Labs by 11.3% during the 2nd quarter. Handelsbanken Fonder AB now owns 44,500 shares of the company’s stock worth $21,494,000 after acquiring an additional 4,500 shares during the period. 60.47% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Astera Labs

In related news, Director Stefan A. Dyckerhoff sold 3,505 shares of the company’s stock in a transaction on Thursday, August 6th. The shares were sold at an average price of $311.83, for a total transaction of $1,092,964.15. Following the completion of the sale, the director directly owned 53,961 shares of the company’s stock, valued at approximately $16,826,658.63. This represents a 6.10% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Manuel Alba sold 8,491 shares of the company’s stock in a transaction on Wednesday, July 1st. The stock was sold at an average price of $458.38, for a total transaction of $3,892,104.58. Following the sale, the director directly owned 286,863 shares of the company’s stock, valued at approximately $131,492,261.94. This trade represents a 2.87% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 1,256,894 shares of company stock valued at $362,763,135 in the last ninety days. Corporate insiders own 10.40% of the company’s stock.

Astera Labs Price Performance

NASDAQ ALAB opened at $321.61 on Friday. Astera Labs, Inc. has a 1-year low of $97.89 and a 1-year high of $499.48. The firm has a market capitalization of $55.80 billion, a P/E ratio of 159.21 and a beta of 3.84. The business’s 50-day simple moving average is $358.00 and its 200-day simple moving average is $240.20.

Astera Labs (NASDAQ:ALAB) last posted its earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.69 by $0.11. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The firm had revenue of $392.40 million during the quarter, compared to the consensus estimate of $360.85 million. During the same quarter in the prior year, the company earned $0.44 EPS. The company’s revenue was up 104.5% on a year-over-year basis. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, equities research analysts expect that Astera Labs, Inc. will post 2.7 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several research firms recently issued reports on ALAB. Evercore reissued an “outperform” rating and issued a $297.00 target price on shares of Astera Labs in a research report on Tuesday, May 19th. Needham & Company LLC upped their price target on shares of Astera Labs from $260.00 to $425.00 and gave the stock a “buy” rating in a research report on Wednesday, August 5th. TD Cowen cut their price target on shares of Astera Labs from $425.00 to $375.00 and set a “hold” rating on the stock in a research note on Wednesday, August 5th. UBS Group reiterated a “neutral” rating and issued a $425.00 price target on shares of Astera Labs in a report on Wednesday, August 5th. Finally, Bank of America lifted their price target on shares of Astera Labs from $240.00 to $450.00 and gave the company a “neutral” rating in a report on Tuesday, June 23rd. One equities research analyst has rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and nine have given a Hold rating to the company. According to data from MarketBeat, Astera Labs presently has a consensus rating of “Moderate Buy” and a consensus price target of $325.25.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.